Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Chang, Ming Ling ^a,b   Yeh, Chau Ting ^a,b   Lin, Deng Yn ^a,b   Ho, Yu Pin ^a,b   Hsu, Chen Ming ^a,b   Bissell, D Montgomery ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CORE PROTEIN; DECAY ACCELERATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; IN VIVO STUDY; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

EID: 69549138347     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-51     Document Type: Article

References (30)

1. Natural history of chronic hepatitis C. LB Seeff, Hepatology 2002 36 5 Suppl 1 S35 46 10.1002/hep.1840360706 12407575
2. The natural history of hepatitis C. NH Afdhal, Semin Liver Dis 2004 24 3 8 10.1055/s-2004-832922 15346240
3. Steatosis in chronic hepatitis C: why does it really matter? T Asselah L Rubbia-Brandt P Marcellin F Negro, Gut 2006 55 123 130 16344578 10.1136/gut.2005.069757 (Pubitemid 41820647)
4. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. G Fattovich T Stroffolini I Zagni F Donato, Gastroenterology 2004 127 S35 S50 10.1053/j.gastro.2004.09.014 15508101 (Pubitemid 39423368)
5. Hepatitis C and nonalcoholic fatty liver disease. S Ramesh AJ Sanyal, Semin Liver Dis 2004 24 399 413 10.1055/s-2004-860869 15605308 (Pubitemid 40052631)
6. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. TJ Liang T Heller, Gastroenterology 2004 127 S62 S71 10.1053/j.gastro.2004.09.017 15508105 (Pubitemid 39423371)
7. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Y Sato J Kato R Takimoto K Takada Y Kawano K Miyanishi M Kobune Y Sato T Takayama T Matunaga Y Niitsu, Gut 2006 55 1801 1808 10.1136/gut.2005.070417 16581947 (Pubitemid 44893582)
8. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. T Fukutomi Y Zhou S Kawai H Eguchi JR Wands J Li, Histology 2005 41 1096 1105
9. Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice. ML Chang JC Chen CT Yeh IS Sheen DI Tai MY Chang CT Chiu DY Lin DM Bissell, World J Gastroenterol 2007 13 3472 3477 17659694
10. Acute expression of hepatitis C core protein in adult mouse liver: mitochondrial stress and apoptosis. ML Chang JC Chen MY Chang CT Yeh WP Lin CK Liang SF Huang KN Dang CT Chiu DY Lin, Scand J Gastroenterol 2008 43 747 55 10.1080/00365520701875987 18569993 (Pubitemid 351868707)
11. The lipid droplet is an important organelle for hepatitis C virus production. Y Miyanari K Atsuzawa N Usuda K Watashi T Hishiki M Zayas R Bartenschlager T Wakita M Hijikata K Shimotohno, Nat Cell Biol 2007 9 1089 1097 10.1038/ncb1631 17721513 (Pubitemid 47338147)
12. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. M Okuda K Li MR Beard LA Showalter F Scholle SM Lemon SA Weinman, Gastroenterology 2002 122 366 375 10.1053/gast.2002.30983 11832451
13. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. K Moriya H Fujie Y Shintani H Yotsuyanagi T Tsutsumi K Ishibashi Y Matsuura S Kimura T Miyamura K Koike, Nat Med 1998 4 1065 1067 10.1038/2053 9734402 (Pubitemid 28417341)
14. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. K Moriya K Nakagawa T Santa Y Shintani H Fujie H Miyoshi T Tsutsumi T Miyazawa K Ishibashi T Horie K Imai T Todoroki S Kimura K Koike, Can Res 2001 61 4365 4370
15. PPAR alpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. N Tanaka K Moriya K Kiyosawa K Koike FJ Gonzalez T Aoyama, J Clin Invest 2008 118 683 94 18188449
16. Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection. SH Yap M Willems J Van den Oord W Habets JM Middeldorp JA Hellings F Nevens H Moshage V Desmet J Fevery, J Hepatol 1994 20 275 281 10.1016/S0168-8278(05)80069-8 7516360
17. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. ML Chang CT Yeh JC Chen CC Huang SM Lin IS Sheen DI Tai CM Chu WP Lin MY Chang CK Liang CT Chiu DY Lin, BMC Genomics 2008 29 9 109 10.1186/1471-2164-9-109
18. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. R Wang LD Ferrell S Faouzi JJ Maher JM Bishop, J Cell Biol 2001 153 1023 1034 11381087 10.1083/jcb.153.5.1023 (Pubitemid 34289241)
19. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. A Kistner M Gossen F Zimmermann J Jerecic C Ullmer H Lübbert H Bujard, Proc Natl Acad Sci USA 1996 93 10933 10938 8855286 10.1073/pnas.93.20.10933 (Pubitemid 26333095)
20. Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo. CL Harris AS Williams SM Linton BP Morgan, Clin Exp Immunol 2002 129 198 207 12165074 10.1046/j.1365-2249.2002.01924.x
21. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proc Natl Acad Sci USA 2001 24 98 5116 5121 10.1073/pnas.091062498 (Pubitemid 32397092)
22. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. M Korenaga T Wang Y Li LA Showalter T Chan J Sun SA Weinman, J Biol Chem 2005 280 37481 37488 10.1074/jbc.M506412200 16150732 (Pubitemid 41642356)
23. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. N Nieto SL Friedman AI Cederbaum, Hepatology 2002 35 62 73 10.1053/jhep.2002.30362 11786960 (Pubitemid 34032544)
24. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. ZQ Yao DT Nguyen AI Hiotellis YS Hahn, J Immunol 2001 167 5264 5272 11673541
25. Therapeutic inhibition of the complement system. SC Makrides, Pharmacol Rev 1998 50 59 87 9549758
26. A central role for central tolerance. B Kyewski L Klein, Ann Rev Immunol 2006 24 571 606 10.1146/annurev.immunol.23.021704.115601
27. Editorial comment: Stroke and the CD40-CD40 ligand system: at the hinge between inflammation and thrombosis. AJ Grau C Lichy, Stroke 2003 34 1417 1418 10.1161/01.STR.0000076520.37414.91 12764236 (Pubitemid 36693509)
28. The impact of the inflammatory response on coagulation. CT Esmon, Thromb Res 2004 114 321 327 10.1016/j.thromres.2004.06.028 15507261 (Pubitemid 39422563)
29. Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. MD Gaça X Zhou RC Benyon, J Hepatol 2002 36 362 369 10.1016/S0168-8278(01)00285-9 11867180 (Pubitemid 34194796)
30. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. S Hillebrandt HE Wasmuth R Weiskirchen C Hellerbrand H Keppeler A Werth R Schirin-Sokhan G Wilkens A Geier J Lorenzen J Köhl AM Gressner S Matern F Lammert, Nat Genet 2005 37 835 843 10.1038/ng1599 15995705 (Pubitemid 41077109)